Martin Fisher

Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.

C. Brander, V. Miller, T. Peto, 2021, Cell reports.

Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population.

A. Miners, A. Speakman, Lorraine Sherr, 2014, The lancet. HIV.

Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses

A. Geretti, Lisa S Burch, A. Speakman, 2016, The Lancet. Public health.

Doctor–patient concordance during HIV treatment switching decision‐making

J. Anderson, H. L. Date, M. Fisher, 2011, HIV medicine.